Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 2.58B | 2.24B |
| Cost of revenue | 668M | 527M |
| Gross profit | 1.92B | 1.71B |
| Research and development | 607M | 585M |
| Selling, general and administrative | 497M | 524M |
| Operating expenses | 1.95B | 1.91B |
| Operating income | −34M | −197M |
| Interest expense | 18M | 36M |
| Pre-tax income | 25M | −107M |
| Income tax | 2M | 5M |
| Net income | 23M | −112M |
| Earnings per share | 0.09 | −0.48 |
| Earnings per share, diluted | 0.09 | −0.48 |
| Weighted average shares | 242M | 234M |
| Weighted average shares, diluted | 254M | 234M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 678M | 768M | 874M | 587M | 914M | 1.08B | 1.08B | 1.18B |
| Receivables | 153M | 149M | 157M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | 368M | 428M |
| Depreciation and amortisation | 264M | 240M |
| Share-based compensation | 390M | 448M |
| Capital expenditure | 133M | 143M |
| Investing cash flow | −6M | 395M |
| Share buybacks | 670M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 151M |
| 115M |
| 104M |
| 117M |
| 115M |
| Current assets | 1.66B | 2.12B | 2.12B | 1.82B | 2.15B | 2.33B | 2.67B | 3.13B |
| Property, plant and equipment | 352M | 350M | 371M | 373M | 364M | 360M | 356M | 356M |
| Goodwill | 2.82B | 2.82B | 2.82B | 2.82B | 2.82B | 2.82B | 2.82B | 2.82B |
| Total assets | 5.23B | 5.69B | 5.70B | 5.42B | 5.75B | 5.83B | 6.16B | 6.63B |
| Current liabilities | 724M | 679M | 584M | 546M | 875M | 831M | 854M | 1.48B |
| Total liabilities | 818M | 801M | 706M | 670M | 992M | 981M | 1.50B | 2.13B |
| Equity | 4.41B | 4.88B | 4.99B | 4.75B | 4.75B | 4.85B | 4.66B | 4.50B |
| 301M |
| Financing cash flow | −674M | −1.23B |